Cargando…

Totality of Evidence Supporting the Use of ABP 980, a Trastuzumab Biosimilar: Practical Considerations

ABP 980 (KANJINTI™, Amgen, Thousand Oaks, CA, USA; Amgen Europe B.V., The Netherlands) is a biosimilar to trastuzumab (Herceptin(®)), a monoclonal antibody that selectively binds human epidermal growth factor receptor-2 (HER2). Here we provide a brief overview of the totality of evidence (including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolberg, Hans-Christian, Demetriou, Georgia Savva, Hanes, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Practical Approach
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297514/ https://www.ncbi.nlm.nih.gov/pubmed/33428085 http://dx.doi.org/10.1007/s40487-020-00129-x

Ejemplares similares

Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab
por: Kolberg, Hans-Christian, et al.
Publicado: (2019)

The Totality of Evidence and Use of ABP 215, a Biosimilar to Bevacizumab
por: Goldschmidt, Jerome, et al.
Publicado: (2020)

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study
por: Kolberg, Hans-Christian, et al.
Publicado: (2020)

Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
por: Jassem, Shea, et al.
Publicado: (2019)

Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
por: Hutterer, Katariina M., et al.
Publicado: (2019)

A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects
por: Hanes, Vladimir, et al.
Publicado: (2017)

Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre
por: Matovina, Sabine, et al.
Publicado: (2022)

A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
por: Markus, Richard, et al.
Publicado: (2019)

A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar
por: Reinisch, Walter, et al.
Publicado: (2021)

A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjects
por: Hanes, Vladimir, et al.
Publicado: (2021)

Evidence-Based Recommendations for the Oral Health of Patients with Parkinson’s Disease
por: Martimbianco, Ana L. C., et al.
Publicado: (2021)

A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
por: Markus, Richard, et al.
Publicado: (2017)

Integration of Physician and Nursing Professional Efforts to Deliver Supportive Scalp Cooling Care to Oncology Patients at Risk for Alopecia
por: Peterson, Lindsay L., et al.
Publicado: (2020)

Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes
por: Lewis, Dana M., et al.
Publicado: (2022)

Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
por: Markus, Richard, et al.
Publicado: (2017)

A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjects
por: Hanes, Vladimir, et al.
Publicado: (2018)

Practical Considerations for Integrating Biosimilars Into Clinical Practice
por: May, Megan B., et al.
Publicado: (2021)

Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
por: Velayudhan, Jyoti, et al.
Publicado: (2016)

Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab
por: Seo, Neungseon, et al.
Publicado: (2018)

Phase 3 LILAC study sets standard for clinical evaluation of oncology biosimilars
por: Kolberg, Hans-Christian, et al.
Publicado: (2019)

COUGH: A PRACTICAL APPROACH FOR THE PRIMARY CARE PHYSICIAN IN SAUDI ARABIA
por: Qutub, Hatem O.
Publicado: (2000)

A Practical Approach to Gastrointestinal Complications of Diabetes
por: Maisey, Abigail
Publicado: (2016)

Practical Approaches to Diabetes Care: An Introduction
por: Evans, Marc, et al.
Publicado: (2016)

Practical Approaches to Diagnosing, Treating and Preventing Hypoglycemia in Diabetes
por: Evans Kreider, Kathryn, et al.
Publicado: (2017)

Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis
por: Bluett, James, et al.
Publicado: (2017)

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis
por: Wilton, Katelynn M., et al.
Publicado: (2017)

Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals
por: Funston, Garth, et al.
Publicado: (2018)

Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
por: Berard, Lori, et al.
Publicado: (2018)

Diabetes in the Elderly
por: Kalra, Sanjay, et al.
Publicado: (2018)

A Practical Guide to Delivering Nutritional Advice to People with Diabetes
por: Dyson, Pamela A.
Publicado: (2019)

Tailored Healthcare: Two Perspectives on the Development and Use of Patient Profiles
por: Dekkers, Tessa, et al.
Publicado: (2018)

Diabetes Distress or Major Depressive Disorder? A Practical Approach to Diagnosing and Treating Psychological Comorbidities of Diabetes
por: Kreider, Kathryn Evans
Publicado: (2017)

Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach
por: van Dijk, Elon H. C., et al.
Publicado: (2020)

XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
por: Panarelli, Joseph F., et al.
Publicado: (2020)

Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare Practitioners
por: Reed, Mollie, et al.
Publicado: (2020)

Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization
por: Piquero-Casals, Jaime, et al.
Publicado: (2020)

Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
por: Attri, Bhawna, et al.
Publicado: (2020)

Improving the Timely Detection of Bladder and Kidney Cancer in Primary Care
por: Zhou, Yin, et al.
Publicado: (2019)

Management Issues in Conjunctival Tumours: Conjunctival Melanoma and Primary Acquired Melanosis
por: Cohen, Victoria M. L., et al.
Publicado: (2019)

Recognising Skin Cancer in Primary Care
por: Jones, Owain T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8etlndvscs7d11rvsthg2isif1